French version validation of the psychotic symptom rating scales (PSYRATS) for outpatients with persistent psychotic symptoms

BMC Psychiatry

Fabienne Giuliani¹  Charles Bonsack¹  Stéphane Morandi¹  Claude Hayoz²  Sabrina Bardy¹  Pascale Ferrari¹  Shyhrete Rexhaj¹  Jerome Favrod¹ 

[1] Department of Psychiatry, Community Psychiatry Service, University Hospital Center of Lausanne, Lausanne, Switzerland;Fondation HorizonSud, Marsens, Switzerland

关键词: Validity;    Reliability;    PANSS;    PSYRATS;    Schizophrenia;    Delusion;    Hallucination;   

Others  :  1124270
DOI  :  10.1186/1471-244X-12-161

 received in 2012-03-22, accepted in 2012-09-25,  发布年份 2012

【 摘 要 】

Background

Most scales that assess the presence and severity of psychotic symptoms often measure a broad range of experiences and behaviours, something that restricts the detailed measurement of specific symptoms such as delusions or hallucinations. The Psychotic Symptom Rating Scales (PSYRATS) is a clinical assessment tool that focuses on the detailed measurement of these core symptoms. The goal of this study was to examine the psychometric properties of the French version of the PSYRATS.

Methods

A sample of 103 outpatients suffering from schizophrenia or schizoaffective disorders and presenting persistent psychotic symptoms over the previous three months was assessed using the PSYRATS. Seventy-five sample participants were also assessed with the Positive And Negative Syndrome Scale (PANSS).

Results

ICCs were superior to .90 for all items of the PSYRATS. Factor analysis replicated the factorial structure of the original version of the delusions scale. Similar to previous replications, the factor structure of the hallucinations scale was partially replicated. Convergent validity indicated that some specific PSYRATS items do not correlate with the PANSS delusions or hallucinations. The distress items of the PSYRATS are negatively correlated with the grandiosity scale of the PANSS.

Conclusions

The results of this study are limited by the relatively small sample size as well as the selection of participants with persistent symptoms. The French version of the PSYRATS partially replicates previously published results. Differences in factor structure of the hallucinations scale might be explained by greater variability of its elements. The future development of the scale should take into account the presence of grandiosity in order to better capture details of the psychotic experience.

【 授权许可】

   
2012 Favrod et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13(2):261-276.
• [2]Andreasen NC: The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: The University of Iowa; 1984.
• [3]Overall JE: The Brief Psychiatric Ratin Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 1988, 24:97-99.
• [4]Steel C, Garety PA, Freeman D, Craig E, Kuipers E, Bebbington P, Fowler D, Dunn G: The multidimensional measurement of the positive symptoms of psychosis. Int J Methods Psychiatr Res 2007, 16(2):88-96.
• [5]Mizrahi R, Kiang M, Mamo DC, Arenovich T, Bagby RM, Zipursky RB, Kapur S: The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders. Schizophr Res 2006, 88(1–3):111-118.
• [6]Miller LJ: Qualitative changes in hallucinations. Am J Psychiatry 1996, 153(2):265-267.
• [7]Schneider SD, Jelinek L, Lincoln TM, Moritz S: What happened to the voices? A fine-grained analysis of how hallucinations and delusions change under psychiatric treatment. Psychiatry Res 2011, 188(1):13-17.
• [8]Moritz S, Jelinek L: Further evidence for the efficacy of association splitting as a self-help technique for reducing obsessive thoughts. Depress Anxiety 2011, 28(7):574-581.
• [9]Favrod J, Maire A, Bardy S, Pernier S, Bonsack C: Improving insight into delusions: a pilot study of metacognitive training for patients with schizophrenia. J Adv Nurs 2011, 67(2):401-407.
• [10]Khazaal Y, Favrod J, Azoulay S, Finot SC, Bernabotto M, Raffard S, Libbrecht J, Dieben K, Levoyer D, Pomini V: "Michael's Game," a card game for the treatment of psychotic symptoms. Patient Educ Couns 2011, 83(2):210-216.
• [11]Haddock G, McCarron J, Tarrier N, Faragher EB: Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med 1999, 29(4):879-889.
• [12]Drake R, Haddock G, Tarrier N, Bentall R, Lewis S: The Psychotic Symptom Rating Scales (PSYRATS): Their usefulness and properties in first episode psychosis. Schizophr Res 2007, 89(1–3):119-122.
• [13]Kronmuller KT, von Bock A, Grupe S, Buche L, Gentner NC, Ruckl S, Marx J, Joest K, Kaiser S, Vedder H, et al.: Psychometric evaluation of the Psychotic Symptom Rating Scales. Compr Psychiatry 2011, 52(1):102-108.
• [14]Hatton C, Haddock G, Taylor JL, Coldwell J, Crossley R, Peckham N: The reliability and validity of general psychotic rating scales with people with mild and moderate intellectual disabilities: an empirical investigation. J Intellect Disabil Res 2005, 49(Pt 7):490-500.
• [15]Gonzalez JC, Sanjuan J, Canete C, Echanove MJ, Leal C: Evaluation of auditory hallucinations: the PSYRATS scale. Actas Esp Psiquiatr 2003, 31(1):10-17.
• [16]Durham RC, Guthrie M, Morton RV, Reid DA, Treliving LR, Fowler D, Macdonald RR: Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up. Br J Psychiatry 2003, 182:303-311.
• [17]Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, Siddle R, Drake R, Everitt J, Leadley K, et al.: Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry Suppl 2002, 43:s91-97.
• [18]Treatment of schizophrenia 1999: The expert consensus guideline series. J Clin Psychiatry 1999, 60(Suppl 11):3-80.
• [19]Wykes T, Hayward P, Thomas N, Green N, Surguladze S, Fannon D, Landau S: What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophr Res 2005, 77:201-210.
• [20]Fisher DJ, Grant B, Smith DM, Borracci G, Labelle A, Knott VJ: Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified 'optimal' multi-feature paradigm. Int J Psychophysiol 2011, 81(3):245-251.
• [21]Fisher DJ, Labelle A, Knott VJ: Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness. Schizophr Res 2012, 139(1–3):237-245.
• [22]Freeman D, Garety PA, Fowler D, Kuipers E, Bebbington PE, Dunn G: Why do people with delusions fail to choose more realistic explanations for their experiences? An empirical investigation. J Consult Clin Psychol 2004, 72(4):671-680.
• [23]Favrod J, Bardy Linder S, Pernier S, Mouron D, Schwyn C, Bonsack C, Pomini V: Entraînement des habiletés métacognitives avec des personnes atteintes de schizophrénie. In TCC et neurosciences. Edited by Cottraux J. Issy-les-Moulineaux: Elsevier Masson SAS; 2009:103-114.
• [24]Favrod J, Ferrari P: Efficacy of metacognitive trainingto reduce delusions: arandomized clinical trial. Research protocol. Swiss National Science Fundation; 2009:25.
• [25]Schwyn C: Le monitoring de la source, vers une compréhension des hallucinations auditives persistantes. Lausanne: Master thesis: Université de Lausanne, Faculté des sciences sociales et politique, Institut de psychologie; 2007:112.
• [26]Guelfi JD: The PANSS (Positive And Negative Symptom) Scale. Encéphale 1997, 23(Spec No 2):35-38.
• [27]Lancon C, Auquier P, Llorca PM, Martinez JL, Bougerol T, Scotto JC: Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients. Encéphale 1997, 23(1):1-9.
• [28]Chang JS, Yi JS, Ahn YM, Kim JH, Kim YS: Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia. Aust N Z J Psychiatry 2009, 43(3):244-251.
• [29]Nayani TH, David AS: The auditory hallucination: a phenomenological survey. Psychol Med 1996, 26(1):177-189.
• [30]Moritz S, Favrod J, Andreou C, Morrison AP, Bohn F, Veckenstedt R, Tonn P, Karow A: Beyond the Usual Suspects: Positive Attitudes Towards Positive Symptoms Is Associated With Medication Noncompliance in Psychosis. Schizophr Bull 2012,  .
• [31]Favrod J, Grasset F, Spreng S, Grossenbacher B, Hodé Y: Benevolent voices are not so kind: the functional significance of auditory hallucinations. Psychopathology 2004, 37(6):304-308.